Literature DB >> 405408

Sodium cromoglycate in ragweed-allergic conjunctivitis.

J Greenbaum, D Cockcroft, F E Hargreave, J Dolovich.   

Abstract

Sodium cromoglycate (SCG), in a 4% solution instilled into each eye 4 times daily, was compared with placebo in a double-blind, noncrossover trial in 30 matched patients with troublesome ragweed pollen-induced conjunctivitis. In the SCG group, eye symptom scores were significantly less (p = 0.05), and all patients judged that their symptoms were improved over the previous year (p less than 0.05). Less antihistamine was used by the SCG group but the difference was not significant. It was concluded that SCG was effective in the treatment of ragweed-induced seasonal allergic conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405408     DOI: 10.1016/0091-6749(77)90006-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease.

Authors:  E M Sorkin; A Ward
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

2.  The management of hay fever in general practice.

Authors:  R W Harland
Journal:  J R Coll Gen Pract       Date:  1979-05

Review 3.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 4.  Drug treatment of allergic conjunctivitis. A review of the evidence.

Authors:  G Ciprandi; S Buscaglia; P M Cerqueti; G W Canonica
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 5.  Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.

Authors:  Christopher G Owen; Anupa Shah; Katherine Henshaw; Liam Smeeth; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.